ACTRN12611000988954招募中未知
The safety and efficacy of tumour pulsed dendritic cells and cytokine induced killer cells for lymphoma and later stage pancreatic carcinoma treatment ex vivo
The First Teaching Hospital, Inner Mongolia Medical College0 个研究点目标入组 30 人开始时间: 2011年9月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 12 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Karnofsky score> 70; low possible maintenance dose of glucocorticoid therapy (Prednisone 10mg/day, less than one month); no allergy to components of the DCs and CIKs.
排除标准
- •cachexia; HIV positive; drug addictive, pregnant; severe pulmonary and cardiac diseases; history of an autoimmune disorder and prior history of other malignancies
研究者
相似试验
已完成
不适用
Clinical safety of peptide pulsed dendritic cell vaccine after radiofrequency ablation for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000020811Kanazawa University10
已完成
不适用
Clinical study of autologous tumor lysate-pulsed dendritic cell therapy after resection of lung cancerlung cancerJPRN-UMIN000005776Seta Clinic Fukuoka8
已完成
1 期
Clinical study of autologous tumor lysate-pulsed dendritic cell therapy for advanced colorectal cancer (Stage3, 4)colorectal cancer (Stage3, 4)JPRN-UMIN000005929Tomishiro Central Hospital15
已完成
1 期
A clinical study on the safety of dendritic cell vaccine pulsed with neoantigen peptides for malignant tumor.JPRN-UMIN000032981KOUSHIKAI,Non-profitmedicalcorporation5
未知
1 期
Dendritic cell therapy and intratumor dendritic cell injection therapy using Tumor associated antigen or tumor lysate for patients with advanced and recurrent canceradvanced and recurrent cancerJPRN-UMIN000000775Fukushima Medical University25